VANCOUVER, Sept. 25 /CNW/ - Dragon Pharmaceutical Inc. ("Dragon Pharma"
or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international
pharmaceutical company, today announced that Ms. Maggie Deng, Chief Operating
Officer and Mr. Garry Wong, Chief Financial Officer will present at 9:30 a.m.
ET on Friday, October 3, 2008 at BioContact Quebec 2008 at the Chateau
Frontenac hotel in Quebec City, Canada.
Ms. Maggie Deng and Mr. Garry Wong will present Dragon Pharma's business
overview including product lines, competitive strengths, and key growth
BioContact Quebec 2008 is a biopharmaceutical partnership symposium that
brings together over 1,200 participants from biopharmaceutical companies to
present various sectors and disciplines of their companies. The conference
will be held on October 1-3, for more information about the conference, please
About Dragon Pharmaceutical Inc.
Dragon Pharmaceutical, headquartered in Vancouver, Canada, is a leading
manufacturer and distributor of a broad line of high-quality antibiotic
products including 7-ACA, a key intermediate to produce cephalosporin
antibiotics, clavulanic acid, and formulated cephalosporin antibiotic drugs.
Dragon is the third largest 7-ACA producer and the first manufacturer and
market leader of clavulanic acid products in China. Dragon utilizes its
nationwide sales distribution network, close customer relationships,
understanding of local markets and customer needs and low cost structure to
outperform its international and domestic peers. With an annual capacity of
780 tons, Dragon is the largest exporter of 7-ACA in China. To learn more
about Dragon Pharmaceutical Inc., please visit www.dragonpharma.com.
For further information:
For further information: Dragon Pharmaceutical Inc., Maggie Deng, Chief
Operating Officer or Karen Huang, Manager, Business Research & Development,
Telephone: (604) 669-8817 or North America Toll Free: 1-877-388-3784, Email:
firstname.lastname@example.org, Website: http://www.dragonpharma.com